Ertapenem Injection, Powder, Lyophilized, For Solution
Product Images NDC 42023-221

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ertapenem (NDC 42023-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ertapenem 01)

FDA Label Image

Principal Display Panel (1 g Vial Tray Label)

Principal Display Panel (1 g Vial Tray Label)
This is a drug product. It comes in the form of 10 single-dose vials, each containing 1 gram of Ertapenem Sodium for intravenous or intramuscular use. It is formulated in France and manufactured for Par Pharmaceutical in Chestnut Ridge, NY. Inactive ingredients include sodium bicarbonate and sodium hydroride to adjust the pH. The solutions range from colorless to pale yellow. The expiration date and lot number are also provided, but instructions for reconstitution, dilution, and usual dosage are not. The packaging includes a warning to discard any unused portion and to not store the lyophilized powder above 25°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.